Jeffrey Zekaukas
Stock Analyst at JP Morgan
(1.13)
# 3,699
Out of 5,182 analysts
31
Total ratings
35.29%
Success rate
-4.43%
Average return
Main Sectors:
Stocks Rated by Jeffrey Zekaukas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EMN Eastman Chemical Company | Upgrades: Overweight | $70 → $80 | $73.64 | +8.64% | 10 | Apr 14, 2026 | |
| MOS The Mosaic Company | Downgrades: Underweight | $24 | $24.33 | -1.36% | 9 | Feb 26, 2026 | |
| ECL Ecolab | Downgrades: Neutral | $200 → $220 | $276.75 | -20.51% | 5 | Feb 14, 2024 | |
| LYB LyondellBasell Industries | Upgrades: Overweight | $95 → $100 | $66.86 | +49.57% | 3 | Feb 5, 2024 | |
| AVY Avery Dennison | Maintains: Overweight | $185 → $218 | $172.82 | +26.14% | 2 | Feb 1, 2024 | |
| LLY Eli Lilly and Company | Maintains: Equal-Weight | $148 → $157 | $925.12 | -83.03% | 2 | Aug 14, 2020 |
Eastman Chemical Company
Apr 14, 2026
Upgrades: Overweight
Price Target: $70 → $80
Current: $73.64
Upside: +8.64%
The Mosaic Company
Feb 26, 2026
Downgrades: Underweight
Price Target: $24
Current: $24.33
Upside: -1.36%
Ecolab
Feb 14, 2024
Downgrades: Neutral
Price Target: $200 → $220
Current: $276.75
Upside: -20.51%
LyondellBasell Industries
Feb 5, 2024
Upgrades: Overweight
Price Target: $95 → $100
Current: $66.86
Upside: +49.57%
Avery Dennison
Feb 1, 2024
Maintains: Overweight
Price Target: $185 → $218
Current: $172.82
Upside: +26.14%
Eli Lilly and Company
Aug 14, 2020
Maintains: Equal-Weight
Price Target: $148 → $157
Current: $925.12
Upside: -83.03%